QuidelOrtho (QDEL) Cash from Operations (QoQ) (2023 - 2026)
QuidelOrtho (QDEL) Cash from Operations (QoQ) (2023 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.27 Bn | 175.98 Bn | 6.27 Bn |
| 2 | Stryker | 128.81 Bn | 125.93 Bn | 3.81 Bn |
| 3 | Medtronic | 108.63 Bn | 99.41 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.42 Bn | 66.96 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.51 Bn | 44.84 Bn | 1.29 Bn |
| 6 | Dexcom | 28.39 Bn | 27.27 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.31 Bn | 26.03 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.93 Bn | 26.35 Bn | - |
| 9 | Koninklijke Philips | 25.47 Bn | 22.35 Bn | 2.07 Bn |
| 10 | QuidelOrtho | 1.18 Bn | 1.04 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 29, 2026 | -125.02% |
| Dec 28, 2025 | 389.89% |
| Sep 28, 2025 | 2.78% |
| Jun 29, 2025 | -171.34% |
| Mar 30, 2025 | 2.98% |
| Dec 29, 2024 | -45.97% |
| Sep 29, 2024 | 220.43% |
| Jun 30, 2024 | -13,885.71% |
| Mar 31, 2024 | -100.87% |
| Dec 31, 2023 | 93.73% |
| Oct 1, 2023 | 235.62% |
| Jul 2, 2023 | -116.20% |
| Apr 2, 2023 | -52.87% |